Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Intelligent Bio Solutions Q3 EPS $(1.43) Beats $(2.52) Estimate

Author: Benzinga Newsdesk | May 08, 2024 08:37am
Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(1.43) per share which beat the analyst consensus estimate of $(2.52) by 43.25 percent. This is a 97.92 percent increase over losses of $(68.64) per share from the same period last year.

Posted In: INBS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist